# Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children

> **NCT00565955** · PHASE3 · COMPLETED · sponsor: **All India Institute of Medical Sciences** · enrollment: 116 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00565955
- **Lead sponsor:** All India Institute of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2008-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00565955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00565955, "Effect of Addition of Oral Montelukast to Standard Treatment in Acute Moderate to Severe Asthma in Children". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00565955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*